Natalia Szałaj

Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended <i>In Cellulo</i>, <i>In Silico</i>, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents

Anna Pasieka, Dawid Panek, Natalia Szałaj et al. · ACS Chemical Neuroscience · 2021 · 76 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta

Michalina Hebda, Marek Bajda, Anna Więckowska et al. · Molecules · 2016 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors

Ornella Di Pietro, Nelson Alencar, Gerard Esteban et al. · Bioorganic & Medicinal Chemistry · 2016 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ₁₋₄₂ Aggregation Inhibitors for Alzheimer's Disease Therapy

Youssef Dgachi, Lhassane Ismaïli, Damijan Knez et al. · ChemMedChem · 2016 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Cholinesterase inhibitory activity of chlorophenoxy derivatives—Histamine H3 receptor ligands

Dorota Łażewska, Jakub Jończyk, Marek Bajda et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16